Tags

Type your tag names separated by a space and hit enter

Advantages to using capillary blood beta-hydroxybutyrate determination for the detection and treatment of diabetic ketosis.
Diabetes Metab 2005; 31(4 Pt 1):401-6DM

Abstract

Ketone body determination is indicated in all diabetic patients when the risk of ketotic decompensation exists. New methods of screening for ketosis, in particular capillary blood ketone body determination, provide analytical, technical and clinical advantages compared to the conventional ketonuria. It is proposed that a diabetic patient with hyperglycaemia (capillary blood glucose > 2.50 g.l(-1)) and capillary blood ketone bodies exceeding 0.5 mmol.l(-1) requires therapeutic management. For values greater than 3 mmol.l(-1) or in case of more serious clinical symptoms, hospitalisation is indicated, considering the high probability of ketoacidotic decompensation. The advantages of capillary blood ketone body determination including easy use, and rapid and objective results may improve management of the diabetic patient, especially in emergency situations. However, prescription by a physician of capillary blood ketone body determination should be offered to targeted populations that have a high risk of ketoacidotic decompensation, after providing education to patients that is above all aimed at preventing this metabolic complication. In this context of determining ketone bodies in capillary blood, the term "capillary blood ketone bodies" is therefore preferable to the term "capillary blood beta-hydroxybutyrate determination". Indeed, it appears more appropriate, simple, descriptive and significant both for health-care staff and for patients.

Authors+Show Affiliations

Service de Diabétologie, Maladies Métaboliques et Nutrition, Hôpital Jeanne d'Arc, Route Nationale 4, 54201 Dommartin lès Toul. b.guerci@chu-nancy.frNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

16369204

Citation

Guerci, B, et al. "Advantages to Using Capillary Blood Beta-hydroxybutyrate Determination for the Detection and Treatment of Diabetic Ketosis." Diabetes & Metabolism, vol. 31, no. 4 Pt 1, 2005, pp. 401-6.
Guerci B, Tubiana-Rufi N, Bauduceau B, et al. Advantages to using capillary blood beta-hydroxybutyrate determination for the detection and treatment of diabetic ketosis. Diabetes Metab. 2005;31(4 Pt 1):401-6.
Guerci, B., Tubiana-Rufi, N., Bauduceau, B., Bresson, R., Cuperlier, A., Delcroix, C., ... Hanaire-Broutin, H. (2005). Advantages to using capillary blood beta-hydroxybutyrate determination for the detection and treatment of diabetic ketosis. Diabetes & Metabolism, 31(4 Pt 1), pp. 401-6.
Guerci B, et al. Advantages to Using Capillary Blood Beta-hydroxybutyrate Determination for the Detection and Treatment of Diabetic Ketosis. Diabetes Metab. 2005;31(4 Pt 1):401-6. PubMed PMID: 16369204.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Advantages to using capillary blood beta-hydroxybutyrate determination for the detection and treatment of diabetic ketosis. AU - Guerci,B, AU - Tubiana-Rufi,N, AU - Bauduceau,B, AU - Bresson,R, AU - Cuperlier,A, AU - Delcroix,C, AU - Durain,D, AU - Fermon,C, AU - Le Floch,J P, AU - Le Devehat,C, AU - Melki,V, AU - Monnier,L, AU - Mosnier-Pudar,H, AU - Taboulet,P, AU - Hanaire-Broutin,H, PY - 2005/12/22/pubmed PY - 2006/1/13/medline PY - 2005/12/22/entrez SP - 401 EP - 6 JF - Diabetes & metabolism JO - Diabetes Metab. VL - 31 IS - 4 Pt 1 N2 - Ketone body determination is indicated in all diabetic patients when the risk of ketotic decompensation exists. New methods of screening for ketosis, in particular capillary blood ketone body determination, provide analytical, technical and clinical advantages compared to the conventional ketonuria. It is proposed that a diabetic patient with hyperglycaemia (capillary blood glucose > 2.50 g.l(-1)) and capillary blood ketone bodies exceeding 0.5 mmol.l(-1) requires therapeutic management. For values greater than 3 mmol.l(-1) or in case of more serious clinical symptoms, hospitalisation is indicated, considering the high probability of ketoacidotic decompensation. The advantages of capillary blood ketone body determination including easy use, and rapid and objective results may improve management of the diabetic patient, especially in emergency situations. However, prescription by a physician of capillary blood ketone body determination should be offered to targeted populations that have a high risk of ketoacidotic decompensation, after providing education to patients that is above all aimed at preventing this metabolic complication. In this context of determining ketone bodies in capillary blood, the term "capillary blood ketone bodies" is therefore preferable to the term "capillary blood beta-hydroxybutyrate determination". Indeed, it appears more appropriate, simple, descriptive and significant both for health-care staff and for patients. SN - 1262-3636 UR - https://www.unboundmedicine.com/medline/citation/16369204/Advantages_to_using_capillary_blood_beta_hydroxybutyrate_determination_for_the_detection_and_treatment_of_diabetic_ketosis_ L2 - https://linkinghub.elsevier.com/retrieve/pii/MDOI-DM-09-2005-31-4-1262-3636-101019-200515048 DB - PRIME DP - Unbound Medicine ER -